港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

维立志博-B

68.000

+0.6500.97%

成交量：36.72万

成交额：2,500.59万

市值：135.32亿

市盈率：-39.42

高：68.800

开：67.550

低：67.100

收：67.350

52周最高：83.600

52周最低：63.200

股本：1.99亿

香港流通股本：1.53亿

量比：0.30

换手率：0.24%

股息：- -

股息率：- -

每股收益(LYR):-1.725

净资产收益率：--

总资产收益率：--

市净率：64.35

市盈率(LYR):-39.42

市销率: - -

数据加载中...

总览公司新闻公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻

临床开发全面提速！维立志博-B(09887)TCE双抗Ⅰ期疗效比肩CAR-T，Ⅱ期首例患者成功用药

维立志博-B(09887)：LBL-034 II期试验首例患者成功用药

维立志博-B(09887)：稳定价格行动及稳定价格期间结束

中国资产全面爆发！港股打新最高涨近300%

老虎资讯综合

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/09887"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09887","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","market":"HK","secType":"STK","nameCN":"维立志博-B","latestPrice":68,"timestamp":1756109316530,"preClose":67.35,"halted":0,"volume":367200,"delay":0,"floatShares":153000000,"shares":199000000,"eps":-1.725,"marketStatus":"未开盘","change":0.65,"latestTime":"08-25 16:08:36","open":67.55,"high":68.8,"low":67.1,"amount":25005897,"amplitude":0.025241,"askPrice":68.1,"askSize":100,"bidPrice":68,"bidSize":28800,"shortable":0,"etf":0,"ttmEps":-1.651777067,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756171800000},"marketStatusCode":0,"adr":0,"listingDate":1753372800000,"exchange":"SEHK","adjPreClose":67.35,"openAndCloseTimeList":[[1756085400000,1756094400000],[1756098000000,1756108800000]],"volumeRatio":0.2973028510468995,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","floatShares":153000000,"roa":"--","roe":"--","lyrEps":-1.725,"volumeRatio":0.2973028510468995,"shares":199000000,"dividePrice":0,"high":68.8,"amplitude":0.025241,"preClose":67.35,"low":67.1,"week52Low":63.2,"pbRate":"64.35","week52High":83.6,"institutionHeld":0,"latestPrice":68,"committee":0.99308,"eps":-1.725,"divideRate":0,"volume":367200,"delay":0,"ttmEps":-1.651777067,"open":67.55,"prevYearClose":35,"prevWeekClose":67.35,"prevMonthClose":72.15,"prevQuarterClose":35,"fiveDayClose":75.1,"twentyDayClose":73.3,"sixtyDayClose":35,"earningDate":1756396800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09887\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09887\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09887\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09887\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09887","date":"2025-08-22","current":-41.268557,"percent":0.85,"low":-47.422411,"twenty":-45.0887,"median":-43.050098,"eighty":-41.70245,"high":-39.760016,"avg":-43.284558,"sd":2.073186,"marketCap":13022964375},"quantilePoints":[{"date":"2025-07-25","current":-39.760016,"twenty":-39.760016,"median":-39.760016,"eighty":-39.760016,"marketCap":12652000240},{"date":"2025-08-01","current":-42.800562,"twenty":-46.836196,"median":-44.399434,"eighty":-42.800562,"marketCap":13535375000},{"date":"2025-08-08","current":-41.931377,"twenty":-45.734702,"median":-43.894587,"eighty":-42.800562,"marketCap":13293671875},{"date":"2025-08-15","current":-42.360797,"twenty":-44.683717,"median":-42.975881,"eighty":-41.70245,"marketCap":13409689375},{"date":"2025-08-22","current":-41.268557,"twenty":-45.0887,"median":-43.050098,"eighty":-41.70245,"marketCap":13022964375}],"updateTime":1756154922449},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09887\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562459022","title":"临床开发全面提速！维立志博-B(09887)TCE双抗Ⅰ期疗效比肩CAR-T，Ⅱ期首例患者成功用药","url":"https://stock-news.laohu8.com/highlight/detail?id=2562459022","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562459022?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 19:08","pubTimestamp":1756120139,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月25日，维立志博-B宣布，公司自主研发的GPRC5D/CD3双特异性抗体顺利完成Ⅱ期临床研究首例患者入组，有望成为首个国产靶向GPRC5D的TCE疗法。LBL-034是一款全球独创2:1结构设计的GPRC5D/CD3双特异性抗体，通过优化抗CD3亲和力和空间位阻作用，显著降低了对T细胞的非特异性激活的风险，同时保持高效的T细胞条件激活能力，从而兼具强大抗肿瘤活性和更佳安全性，具备同类最佳潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334638.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09887","BK4022","BK1161","CAR","BK4230"],"gpt_icon":1},{"id":"2562293248","title":"维立志博-B(09887)：LBL-034 II期试验首例患者成功用药","url":"https://stock-news.laohu8.com/highlight/detail?id=2562293248","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562293248?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 18:29","pubTimestamp":1756117773,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维立志博-B(09887)发布公告，LBL-034(GPRC5D/CD3双特异性抗体)I期数据亮眼，II期试验首例患者成功用药。这标志着集团LBL-034临床研究取得里程碑成就，为推进后续临床试验奠定坚实基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09887","BK1161"],"gpt_icon":0},{"id":"2561469612","title":"维立志博-B(09887)：稳定价格行动及稳定价格期间结束","url":"https://stock-news.laohu8.com/highlight/detail?id=2561469612","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561469612?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 18:40","pubTimestamp":1755772837,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维立志博-B 发布公告，有关全球发售的稳定价格期间于2025年8月21日(星期四)结束。于稳定价格期间，稳定价格操作人并无在市场上买卖任何H股以稳定价格。紧随稳定价格期间结束后，公司将继续遵守上市规则第19A.13A条的公众持股量规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1332886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","09887"],"gpt_icon":0},{"id":"1141757368","title":"中国资产全面爆发！港股打新最高涨近300%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141757368","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141757368?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 11:05","pubTimestamp":1755572712,"startTime":"0","endTime":"0","summary":"8月19日，中国资产全面爆发，A股沪指创近10年新高！港股IPO持续势如破竹，7月以来上市12支，首日10支收涨，2支收跌，胜率高达83.33%！累计一手收益可达15,367港元。📢 双登股份（06960）正在火热申购中🔥🚩 申购方式：【老虎国际App】-【持仓】-【IPO】✨ 老虎打新优势：✅ 现金申购0手续费，融资申购0孖展利息✅ 10倍杠杆，额度充足✅ 支持暗盘交易，快人一步抢占先机✅ TOP科技券商，安全可靠","market":"hk","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"中国资产全面爆发！港股打新最高涨近300%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887","02627","06960","02591"],"gpt_icon":0}],"pageSize":4,"totalPage":21,"pageCount":1,"totalSize":81,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/09887\",params:#limit:6,delay:false,,,undefined,":[]}}